Impact of genetic variant of HIPK2 on the risk of severe radiation pneumonitis in lung cancer patients treated with radiation therapy
Abstract Background Homeodomain-interacting protein kinase 2 (HIPK2) has increasingly drawn attention as recent researches demonstrated its unique role in the regulation of multiple fundamental processes such as apoptosis, proliferation and DNA damage repair. Most importantly, HIPK2 was shown to pla...
Main Authors: | Yang Tang, Li Yang, Wan Qin, Min’ Xiao Yi, Bo Liu, Xiang’Lin Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-019-1456-0 |
Similar Items
-
The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation
by: Chengbo Ren, et al.
Published: (2018-04-01) -
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab
by: Narek Shaverdian, et al.
Published: (2020-07-01) -
Radiation Pneumonitis: Old Problem, New Tricks
by: Varsha Jain, et al.
Published: (2018-07-01) -
Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Early Stage
Non-small Cell Lung Cancer
by: Lu CHEN, et al.
Published: (2014-04-01) -
Genetic variants of SP‐D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy
by: Li Xu, et al.
Published: (2019-05-01)